Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Psychiatry/Psychology
Psychosis Clinical Trials
A listing of Psychosis medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.
Arkansas
Little Rock : K&S Professional Research Services, LLC
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
California
Anaheim : South Coast Clinical Trials, Inc
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Costa Mesa : ATP Clinical Research, Inc.
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Downey : Diligent Clinical Trials
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Escondido : Synergy Clinical Research Center
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
San Bernardino : Breakthrough Clinical Trials
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Florida
Hollywood : Segal Institute for Clinical Research
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Miami : AMB Research Center
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Georgia
Atlanta : Wesley Woods Geriatric Hospital
A Comparison of Two Standard Therapies in the Management of Dementia With Agitation
Atlanta : Atlanta Center for Medical Research
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Illinois
Hoffman Estates : Alexian Brothers Center for Psychiatric Research
A six week randomized, double-blind, multi-center, placebo-contolled, exploratory, adaptive design study to explore the antidepressant properties of the p38 MAP kinase inhibitor GW856553 compound compared to placebo in adult subjects with Major Depressive Disorder.
Missouri
Creve Coeur : Millennium Psychiatric Associate
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
St. Louis : Scientella LLC
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
New Jersey
New Brunswick : Robert Wood Johnson Medical School: University of Medicine & Dentistry of New Jersey
Barriers to Mental Health Care Utilization in Parkinson's Disease
View More »
Marlton : CRI Lifetree
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
New York
Glen Oaks : The Zucker Hillside Hospital
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
North Carolina
Hope Mills : Inquest Clinical Group/ Global Research Associates
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Ohio
Cincinnati : Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation
Neurofibromatosis Type 1 (NF1) Study
View More »
Dayton : Midwest Clinical Research Center
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Oklahoma
Oklahoma City : Oklahoma Clinical Research Center
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Pennsylvania
Allentown : Lehigh Center for Clinical Research
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Pittsburgh : University of Pittsburgh Medical Center (UPMC)
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Texas
Dallas : University of Texas Southwestern Medical Center
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Houston : Claghorn-Lesem Research Clinic
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Houston : Clinical Trial Network
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Utah
Salt Lake City : Lifetree Clinical Research
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Washington
Richland : Scientella, LLC.
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
China
Huzhou :
A Study to Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Patients With Acute Schizophrenia
Shanghai :
A Study to Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Patients With Acute Schizophrenia
Suzhou :
A Study to Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Patients With Acute Schizophrenia
Wenzhou :
A Study to Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Patients With Acute Schizophrenia
Wuxi :
A Study to Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Patients With Acute Schizophrenia
Korea, Republic of
Busan :
A Study to Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Patients With Acute Schizophrenia
Goyang :
A Study to Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Patients With Acute Schizophrenia
Gyeonggi-Do :
A Study to Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Patients With Acute Schizophrenia
Jeonju-Si :
A Study to Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Patients With Acute Schizophrenia
Kyounggi :
A Study to Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Patients With Acute Schizophrenia
View More »
Seoul :
A Study to Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Patients With Acute Schizophrenia
Suwon :
A Study to Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Patients With Acute Schizophrenia
Malaysia
Kuala Lumpur :
A Study to Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Patients With Acute Schizophrenia
Tanjong Rambutan :
A Study to Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Patients With Acute Schizophrenia
Taiwan
Chiayi :
A Study to Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Patients With Acute Schizophrenia
Douliou City, Yunlin County :
A Study to Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Patients With Acute Schizophrenia
Kaohsiung :
A Study to Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Patients With Acute Schizophrenia
Kaohsiung City :
A Study to Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Patients With Acute Schizophrenia
New Taipei City :
A Study to Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Patients With Acute Schizophrenia
View More »
Taichung :
A Study to Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Patients With Acute Schizophrenia
Taipei :
A Study to Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Patients With Acute Schizophrenia
